657 filings
Page 14 of 33
8-K
n525ft1jqyb0tk
16 Aug 16
Other Events
12:00am
8-K
q2ik3vfb fu7p
4 Aug 16
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2016
12:00am
8-K
ulgah6u32ex3zef6bc4r
20 Jun 16
Other Events
12:00am
8-K
55fp6f
1 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
7st1i0akx uesyy
12 May 16
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2016
12:00am
DEFC14A
3t6wmm
21 Apr 16
Proxy in contested solicitation
12:00am
PRER14A
jbx9qc0m74u0
13 Apr 16
Preliminary revised proxy
12:00am
CORRESP
aaev2 gofwb
13 Apr 16
Correspondence with SEC
12:00am
UPLOAD
j4jg8goada3tdt6 pxdh
11 Apr 16
Letter from SEC
12:00am
PREC14A
37s d3ynbczs8a8zae
1 Apr 16
Preliminary proxy with contested solicitation
12:00am
8-K
k2lpio9nyqz4jk80u g5
9 Mar 16
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Year End 2015
12:00am
8-K
oh1f5ljpt3qx 2q
26 Feb 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
u45a5wgpe0br5
4 Feb 16
OncoGenex Announces Reduction in Force to Extend Cash Runway and Align
12:00am
8-K
laxpin44tq6h7vuxa75x
20 Jan 16
OncoGenex Announces Update on Phase 2 Spruce Trial in Previously Untreated
12:00am
8-K
db9bu7pe5
7 Jan 16
Other Events
12:00am
8-K
1jk0aop 4rz
1 Dec 15
OncoGenex Announces Phase 3 AFFINITY Trial with Custirsen Continues Following Interim Analyses
12:00am